Publicou 6 edições por ano
ISSN Imprimir: 1045-4403
ISSN On-line: 2162-6502
Indexed in
Caffeine: A Potential Protective Agent Against Cognitive Decline in Alzheimer’s Disease
RESUMO
Over the past few decades, caffeine has been well recognized as a stimulant whose effects can be detected particularly in the central nervous system. A stimulating effect of caffeine has been found useful in treating patients with many neurological disorders, including Alzheimer's disease (AD). AD is reported to be a rapidly increasing public health problem with lack of a remedial treatment. However, the assumed protective effects of caffeine against AD are of huge interest. This study substantiates caffeine's role as a potential prevention agent against AD through several epidemiological studies. More than 75% of available study reports support the opinion that caffeine has a favorable effect against cognitive decline and AD. Moreover, other studies have discussed the effect of caffeine drinking and concluded several positive effects on cognitive functioning. The present study, however, focuses more on the potential mechanisms by which caffeine diminishes effects as well as delays the onset of AD.
-
Samoggia Antonella, Riedel Bettina, Consumers’ Perceptions of Coffee Health Benefits and Motives for Coffee Consumption and Purchasing, Nutrients, 11, 3, 2019. Crossref
-
Li Mingxue, Bai Ligai, Peng Shan, Sun Fanrong, Wang Laisen, Liu Haiyan, Yan Hongyuan, Simple quantitative analytical methods for the determination of alkaloids from medicinal and edible plant foods using a homemade chromatographic monolithic column, Journal of Chromatography B, 1128, 2019. Crossref
-
Li Mingxue, Bai Ligai, Sun Fanrong, Peng Shan, Liu Haiyan, Ma Zhengyue, Simultaneous Determination of Six Alkaloids in Rat Plasma with On-line SPE–HPLC Using a Homemade Four-Hydrogen Furfuryl-Based Polymer Monolithic Sorbent, Chromatographia, 83, 2, 2020. Crossref
-
Londzin Piotr, Zamora Milena, Kąkol Beata, Taborek Aleksandra, Folwarczna Joanna, Potential of Caffeine in Alzheimer’s Disease—A Review of Experimental Studies, Nutrients, 13, 2, 2021. Crossref
-
Huang Zhao, Xie Na, Illes Peter, Di Virgilio Francesco, Ulrich Henning, Semyanov Alexey, Verkhratsky Alexei, Sperlagh Beata, Yu Shu-Guang, Huang Canhua, Tang Yong, From purines to purinergic signalling: molecular functions and human diseases, Signal Transduction and Targeted Therapy, 6, 1, 2021. Crossref
-
Ramos Claudia, Villalba Camilo, García Jenny, Lanata Serggio, López Hugo, Aguillón David, Cordano Christian, Madrigal Lucía, Aguirre-Acevedo Daniel C., Lopera Francisco, Substance Use-Related Cognitive Decline in Families with Autosomal Dominant Alzheimer’s Disease: A Cohort Study, Journal of Alzheimer's Disease, 85, 4, 2022. Crossref
-
Teixeira Leila Suleimara, Silva Camilla Fonseca, de Oliveira Hanna Leijoto, Dinali Laíse Aparecida Fonseca, Nascimento Clebio Soares, Borges Keyller Bastos, Microextraction by packed molecularly imprinted polymer to selectively determine caffeine in soft and energy drinks, Microchemical Journal, 158, 2020. Crossref
-
Song Wu, Tang Yong, Wei Lin, Zhang Chi, Song Danning, Li Xueting, Jiang Shuang, Protective effect of CD73 inhibitor α, β-methylene ADP against amyloid-β-induced cognitive impairment by inhibiting adenosine production in hippocampus, Electronic Journal of Biotechnology, 48, 2020. Crossref